Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hille

Showing results (91-100 of 119) with videos related to

Pageof 12
Sort By:
American Journal of Hypertension|February 21, 2014
Racial differences in incident atrial fibrillation among hypertensive patients during antihypertensive therapyPeter M Okin, Casper N Bang, Kristian Wachtell, et al.
Cancer Chemotherapy and Pharmacology|July 14, 2025
Unrecognized mutations in DPYD* 2 A wild-type rectal cancer patients receiving postoperative 5-FU-based chemotherapy - do they have a clinical impact?P Liersch, S Dierks, R Andag, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|February 24, 2004
Binding N2, N2H2, N2H4, and NH3 to transition-metal sulfur sites: modeling potential intermediates of biological N2 fixationDieter Sellmann, A Hille, A Rösler, et al.
Vaccine|February 28, 2019
Immunogenicity of pentavalent rotavirus vaccine in Chinese infantsZhaojun Mo, Xiao Ma, Peng Luo, et al.
Virology|August 1, 1993
Immunological detection of proteins associated with the Epstein-Barr virus nuclear antigen 2AF A Grässer, C Sauder, P Haiss, et al.
Journal of the American Society of Nephrology : JASN|December 8, 2004
Continuum of renoprotection with losartan at all stages of type 2 diabetic nephropathy: a post hoc analysis of the RENAAL trial resultsGiuseppe Remuzzi, Piero Ruggenenti, Annalisa Perna, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 14, 2009
Clustered metabolic abnormalities blunt regression of hypertensive left ventricular hypertrophy: the LIFE studyG de Simone, P M Okin, E Gerdts, et al.
Journal of Human Hypertension|May 4, 2007
Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE studyG de Simone, M H Olsen, K Wachtell, et al.
The EMBO Journal|May 1, 1987
The primary structure of human secretogranin I (chromogranin B): comparison with chromogranin A reveals homologous terminal domains and a large intervening variable regionU M Benedum, A Lamouroux, D S Konecki, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 17, 2010
Mediastinal radiotherapy after multidrug chemotherapy and prophylactic cranial irradiation in patients with SCLC--treatment results after long-term follow-up and literature overviewM K A Herrmann, E Bloch, T Overbeck, et al.
Pageof 12

Showing results (91-100 of 119) with videos related to

Sort By:
Pageof 12
American Journal of Hypertension|February 21, 2014
Racial differences in incident atrial fibrillation among hypertensive patients during antihypertensive therapyPeter M Okin, Casper N Bang, Kristian Wachtell, et al.
Cancer Chemotherapy and Pharmacology|July 14, 2025
Unrecognized mutations in DPYD* 2 A wild-type rectal cancer patients receiving postoperative 5-FU-based chemotherapy - do they have a clinical impact?P Liersch, S Dierks, R Andag, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|February 24, 2004
Binding N2, N2H2, N2H4, and NH3 to transition-metal sulfur sites: modeling potential intermediates of biological N2 fixationDieter Sellmann, A Hille, A Rösler, et al.
Vaccine|February 28, 2019
Immunogenicity of pentavalent rotavirus vaccine in Chinese infantsZhaojun Mo, Xiao Ma, Peng Luo, et al.
Virology|August 1, 1993
Immunological detection of proteins associated with the Epstein-Barr virus nuclear antigen 2AF A Grässer, C Sauder, P Haiss, et al.
Journal of the American Society of Nephrology : JASN|December 8, 2004
Continuum of renoprotection with losartan at all stages of type 2 diabetic nephropathy: a post hoc analysis of the RENAAL trial resultsGiuseppe Remuzzi, Piero Ruggenenti, Annalisa Perna, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 14, 2009
Clustered metabolic abnormalities blunt regression of hypertensive left ventricular hypertrophy: the LIFE studyG de Simone, P M Okin, E Gerdts, et al.
Journal of Human Hypertension|May 4, 2007
Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE studyG de Simone, M H Olsen, K Wachtell, et al.
The EMBO Journal|May 1, 1987
The primary structure of human secretogranin I (chromogranin B): comparison with chromogranin A reveals homologous terminal domains and a large intervening variable regionU M Benedum, A Lamouroux, D S Konecki, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 17, 2010
Mediastinal radiotherapy after multidrug chemotherapy and prophylactic cranial irradiation in patients with SCLC--treatment results after long-term follow-up and literature overviewM K A Herrmann, E Bloch, T Overbeck, et al.
Pageof 12